Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Onerji

Onerji (60 mg + 7.5 mg)/mL solution for infusion · Abschnitt 4.8 · PDF-Seite 9–11

HOS-152963 · Präparat HOS-100875

9 System Organ Very common Common Uncommon Not known3 Class Somnolence, Taste disorder Eye disorders Vision blurred, Diplopia, Mydriasis, Oculogyric crisis, Blepharospasm Cardiac Palpitations, disorders Cardiac rhythm disorders Vascular Hypotension Orthostatic Hypertension, disorders hypotension Syncope, Thrombophlebitis, Hot flushes Respiratory, Dyspnoea, thoracic and Respiration mediastinal abnormal, disorders Dysphonia, Hiccups Gastrointestinal Nausea Dry mouth, Abdominal pain, disorders Vomiting Constipation, Diarrhoea, Gastrointestinal haemorrhage, Peptic ulcer, Dysphagia, Dyspepsia, Glossodynia, Flatulence, Saliva discolouration, Salivary hypersecretion Skin and Dermatitis contact Panniculitis, Rash Angioedema, subcutaneous Hyperhidrosis, tissue disorders Pruritus, Henoch- Schonlein purpura, Urticaria, Sweat discolouration, Alopecia Musculoskeletal Pain in extremity Muscle spasms, and connective Trismus tissue disorders Renal and Urinary retention, urinary disorders Chromaturia, Urinary incontinence Reproductive Priapism system and breast disorders General Infusion site Infusion site Asthenia, Fatigue, Malaise, disorders and erythema1, 2, discolouration, Discomfort, Other Gait disturbance, administration Infusion site Infusion site infusion site Chest pain site conditions eschar1, 2, Infusion haemorrhage, reactions1, site haematoma1, 2, Infusion site Peripheral edema1, Infusion site induration, Pyrexia 10  System Organ Very common Common Uncommon Not known3 Class nodule1, 2, Infusion Infusion site site pain1, 2 pruritus, Infusion site reaction (unspecified), Infusion site swelling1, 2, Infusion site vesicles, Therapeutic response shortened Investigations Weight gain, Weight lost Injury, Fall Skin abrasion poisoning and procedural complications Product issues Leakage of medication on the skin that could cause local reaction 1 Grouped terms that include closely related preferred terms. 2 See description of selected adverse reactions. 3 These adverse reactions have not been reported with Onerji, but are expected for oral levodopa.

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.